2008
DOI: 10.1073/pnas.0712390105
|View full text |Cite
|
Sign up to set email alerts
|

Protection from fatal viral encephalomyelitis: AMPA receptor antagonists have a direct effect on the inflammatory response to infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
41
0
1

Year Published

2009
2009
2022
2022

Publication Types

Select...
5
3

Relationship

3
5

Authors

Journals

citations
Cited by 42 publications
(46 citation statements)
references
References 63 publications
4
41
0
1
Order By: Relevance
“…�ack of CNS in�ammation was due to failure of treated mice to induce activation and proliferation of lymphocytes in secondary lymphoid tissue aer infection. Antibody responses were also suppressed by talampanel treatment, and virus clearance was delayed [25]. Also, it has been shown that CD4(+) T cells can promote progressive neuronal death and tissue injury, despite clearance of infectious virus [26].…”
Section: Immunity To Infection Sinv Encephalitis In Mice Hasmentioning
confidence: 83%
“…�ack of CNS in�ammation was due to failure of treated mice to induce activation and proliferation of lymphocytes in secondary lymphoid tissue aer infection. Antibody responses were also suppressed by talampanel treatment, and virus clearance was delayed [25]. Also, it has been shown that CD4(+) T cells can promote progressive neuronal death and tissue injury, despite clearance of infectious virus [26].…”
Section: Immunity To Infection Sinv Encephalitis In Mice Hasmentioning
confidence: 83%
“…Entry of inflammatory cells into the CNS from the periphery is essential for the clearance of infectious virus (14,34), and previous studies have shown that noncytolytic effectors of virus clearance include IFN-␥ and antiviral IgG (4,23). CD8…”
Section: Discussionmentioning
confidence: 99%
“…96 Protection from fatal disease was observed upon treatment with the AMPA receptor antagonist talampanel, a drug currently undergoing clinical evaluation for the treatment of gliomas. 97 Attenuation of CNS inflammation but no decrease in viral replication was observed upon treatment with talampanel, suggesting that compounds capable of decreasing CNS inflammation may provide a therapeutic benefit in alphavirus infections.…”
Section: Candidate Neuroprotective Interventionsmentioning
confidence: 96%